Aligned Marketplace secured $20 million in new funding toward an advanced primary care marketplace, led by Venrock in its Series A. The company said it has raised $31 million to date, positioning the platform for expanded clinical reach and marketplace capabilities. Although the investment is not a drug pipeline event, it directly impacts how care is delivered and paid for, which can influence adoption pathways for digital health tools and evidence generation in real-world settings. For biotech stakeholders, primary care marketplaces can become distribution and data infrastructure for diagnostics, therapeutics, and care-navigation programs, especially where payer/provider alignment is critical. The funding also reflects continued investor appetite for healthcare infrastructure companies that connect clinical workflows with longitudinal patient management.